v3.25.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues:        
Premiums $ 87,905 $ 76,897 $ 174,439 $ 154,885
Investment and other income 1,108 997 2,141 2,008
Total revenues 111,616 98,855 221,191 198,651
Operating costs:        
Medical Costs 78,585 65,458 151,996 131,193
Operating costs 13,778 13,162 27,372 27,239
Cost of products sold 13,019 11,340 25,409 22,396
Depreciation and amortization 1,084 1,020 2,145 2,017
Total operating costs 106,466 90,980 206,922 182,845
Earnings from operations 5,150 7,875 14,269 15,806
Interest expense (1,027) (985) (2,025) (1,829)
Loss on sale of subsidiary and subsidiaries held for sale (41) (1,225) (56) (8,311)
Earnings before income taxes 4,082 5,665 12,188 5,666
Provision for income taxes (510) (1,244) (2,142) (2,466)
Net earnings 3,572 4,421 10,046 3,200
Earnings attributable to noncontrolling interests (166) (205) (348) (393)
Net earnings attributable to UnitedHealth Group common shareholders $ 3,406 $ 4,216 $ 9,698 $ 2,807
Earnings per share attributable to UnitedHealth Group common shareholders:        
Basic $ 3.76 $ 4.58 $ 10.66 $ 3.05
Diluted $ 3.74 $ 4.54 $ 10.61 $ 3.02
Basic weighted-average number of common shares outstanding 907 921 910 921
Dilutive effect of common share equivalents 3 7 4 8
Diluted weighted-average number of common shares outstanding 910 928 914 929
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 13 8 10 7
Products        
Revenues:        
Revenue from Products and Services $ 13,564 $ 12,211 $ 26,600 $ 24,120
Services        
Revenues:        
Revenue from Products and Services $ 9,039 $ 8,750 $ 18,011 $ 17,638